$PLTR

Stat Lauren Elaina Friedman sold $500K of PLTR

Stat Lauren Elaina Friedman sold 3,032 shares of Palantir Technologies Inc. (PLTR) at $165.00 ($0.50M total) on 2026-08-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Stat Lauren Elaina Friedman
Published Aug 8, 2026, 12:11 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 12:39 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PLTR
Neutral
low confidence
Mentioned
$PLTR
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLTRNeutralLow
01

Why it matters

The disclosed event is a director open-market sale of 3,032 shares at $165.00/share, totaling $500,280, executed under a pre-arranged Rule 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but there is no accompanying new company-specific catalyst in the text.

03

What to watch

The article does not state whether other insiders sold/bought around the same period, nor does it provide total insider activity context or any change in Palantir fundamentals.

Relevance 4/10Novelty 3/10Timing: Filed 2026-08-07 for a sale dated 2026-08-05.

Background

The article is a SEC Form 4 insider transaction disclosure for Palantir director Stat Lauren Elaina Friedman.

Company-level read

Ticker impact

$PLTRNeutralLow confidence
Context

Palantir director Stat Lauren Elaina Friedman sold 3,032 shares in an open-market transaction on 2026-08-05 under a 10b5-1 plan.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional signal beyond routine 10b5-1 selling.

Evidence & confidence

The filing is a Form 4 open-market sale by a director with a pre-arranged 10b5-1 plan, and the article provides no new operational, financial, or regulatory catalyst.

Market effects

Minimal; insider sale does not change the software/AI sector outlook on its own.

None indicated.

None indicated.

Counterpoint

10b5-1 plans often reflect scheduled liquidity needs rather than bearish expectations, so the market may overreact to the headline framing.

Key entities

  • Palantir Technologies Inc.

    Subject of the Form 4 insider transaction disclosure (PLTR).

  • Stat Lauren Elaina Friedman

    Director who sold 3,032 shares under a 10b5-1 plan.

Related articles

$RTXMedAI 8/10

Pentagon warns arms makers to accelerate output as U.S. munitions crisis grows

The Pentagon, according to a memo reported by The Washington Post and confirmed by spokesman Sean Parnell, is urging defense contractors to accelerate production of critical munitions within 21 days, citing rapid U.S. missile and interceptor usage in the Iran war. CSIS estimates Patriot and THAAD stocks fell sharply. The memo also ties plans to shaping the fiscal 2028 defense budget.

$PLTRMed

PTIR Jumps 18% as Palantir Stock Rallies Yet Again

GraniteShares 2x Long PLTR Daily ETF (PTIR) rose about 18% after a weak jobs report boosted tech stocks and reduced expectations for a near-term Fed rate hike. The article links the move to Palantir’s Aug. 3 earnings, including Q2 revenue of $1.94B (+92.8% YoY) and raised FY revenue guidance to $8.15B-$8.158B.

$PLTRMedAI 8/10

Why Palantir, Zebra, and Gartner Soared

Palantir (PLTR) shares rose after quarterly results. It reported $1.94B revenue (+94% Y/Y) and forecast Q3 revenue up to $2.164B, above expectations. Gartner (IT) gained after Q2 results, with $1.7B revenue (+1.7% Y/Y) and free cash flow up 8.9% to $378M. Zebra (ZBRA) hit a 52-week high after Q2 EPS of $6.35 and raised full-year EPS range to $20.75-$21.25.